Viewing StudyNCT05191888



Ignite Creation Date: 2024-05-06 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 2:22 PM
Study NCT ID: NCT05191888
Status: RECRUITING
Last Update Posted: 2022-01-14
First Post: 2021-12-28

Brief Title: 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy
Sponsor: Kaohsiung Medical University
Organization: Kaohsiung Medical University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-06
Start Date Type: ACTUAL
Primary Completion Date: 2024-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2021-12-28
First Submit QC Date: January 13 2022
Study First Post Date: 2022-01-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-01-13
Last Update Post Date: 2022-01-14
Last Update Post Date Type: ACTUAL